4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-18-064090
Director bought 245,000 shares at an average $0.42 ($103,247)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MENDLEIN JOHN Director | 2018-12-20 | Purchase | +50,000 | $0.41 | $20,645 | 420,382 | D |
| MENDLEIN JOHN Director | 2018-12-21 | Purchase | +195,000 | $0.42 | $82,602 | 615,382 | D |
| Open-market purchases · 245,000 sh · avg $0.42 · $103,247 | |||||||
Loading xslF345X03/doc4.xml…